BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27256106)

  • 21. Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform.
    Guo W; Yang XR; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang X; Zhou J; Fan J
    Clin Cancer Res; 2014 Sep; 20(18):4794-805. PubMed ID: 25009297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer.
    Amato RJ; Melnikova V; Zhang Y; Liu W; Saxena S; Shah PK; Jensen BT; Torres KE; Davis DW
    Urology; 2013 Jun; 81(6):1303-7. PubMed ID: 23622774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation Between Disease Stage and the Presence of Viable Circulating Tumor Cells in Endometrial Cancer.
    Kiss I; Kolostova K; Matkowski R; Jędryka M; Czekański A; Pavlasek J; Bobek V
    Anticancer Res; 2018 May; 38(5):2983-2987. PubMed ID: 29715128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma.
    Khoja L; Shenjere P; Hodgson C; Hodgetts J; Clack G; Hughes A; Lorigan P; Dive C
    Melanoma Res; 2014 Feb; 24(1):40-6. PubMed ID: 24201293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enumeration, characterisation and clinicopathological significance of circulating tumour cells in patients with colorectal carcinoma.
    Hamid FB; Lu CT; Matos M; Cheng T; Gopalan V; Lam AK
    Cancer Genet; 2021 Jun; 254-255():48-57. PubMed ID: 33610860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumor cells in newly diagnosed inflammatory breast cancer.
    Mego M; Giordano A; De Giorgi U; Masuda H; Hsu L; Giuliano M; Fouad TM; Dawood S; Ueno NT; Valero V; Andreopoulou E; Alvarez RH; Woodward WA; Hortobagyi GN; Cristofanilli M; Reuben JM
    Breast Cancer Res; 2015 Jan; 17(1):2. PubMed ID: 25572591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
    Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
    Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EpCAM
    Nicolazzo C; Gradilone A; Loreni F; Raimondi C; Gazzaniga P
    Dis Markers; 2019; 2019():1718920. PubMed ID: 31636732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical Prostatectomy.
    Thalgott M; Rack B; Horn T; Heck MM; Eiber M; Kübler H; Retz M; Gschwend JE; Andergassen U; Nawroth R
    Anticancer Res; 2015 Oct; 35(10):5679-85. PubMed ID: 26408743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer.
    Peeters DJ; Brouwer A; Van den Eynden GG; Rutten A; Onstenk W; Sieuwerts AM; Van Laere SJ; Huget P; Pauwels P; Peeters M; Vermeulen PB; Dirix LY
    Cancer Lett; 2015 Jan; 356(2 Pt B):872-9. PubMed ID: 25449778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.
    Yin J; Wang Y; Yin H; Chen W; Jin G; Ma H; Dai J; Chen J; Jiang Y; Wang H; Liu Z; Hu Z; Shen H
    PLoS One; 2015; 10(8):e0137076. PubMed ID: 26317979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Müllerian hormone is associated with extrauterine involvement and stage of disease in patients with endometrial cancer.
    Dogan NU; Kerimoglu OS; Karabagli P; Pekin A; Yilmaz SA; Incesu F; Celik C
    J Obstet Gynaecol; 2015 Feb; 35(2):178-82. PubMed ID: 25111828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.
    Rao CG; Chianese D; Doyle GV; Miller MC; Russell T; Sanders RA; Terstappen LW
    Int J Oncol; 2005 Jul; 27(1):49-57. PubMed ID: 15942643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer?
    Koyuncuoglu M; Okyay E; Saatli B; Olgan S; Akin M; Saygili U
    Gynecol Oncol; 2012 Apr; 125(1):208-13. PubMed ID: 22198340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between circulating tumour cell count and prognosis following chemotherapy in patients with advanced non-small-cell lung cancer.
    Zhang Z; Xiao Y; Zhao J; Chen M; Xu Y; Zhong W; Xing J; Wang M
    Respirology; 2016 Apr; 21(3):519-25. PubMed ID: 26661896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges in the enumeration and phenotyping of CTC.
    Coumans FA; Ligthart ST; Uhr JW; Terstappen LW
    Clin Cancer Res; 2012 Oct; 18(20):5711-8. PubMed ID: 23014524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system.
    Nichols AC; Lowes LE; Szeto CC; Basmaji J; Dhaliwal S; Chapeskie C; Todorovic B; Read N; Venkatesan V; Hammond A; Palma DA; Winquist E; Ernst S; Fung K; Franklin JH; Yoo J; Koropatnick J; Mymryk JS; Barrett JW; Allan AL
    Head Neck; 2012 Oct; 34(10):1440-4. PubMed ID: 22076949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer.
    Brungs D; Minaei E; Piper AK; Perry J; Splitt A; Carolan M; Ryan S; Wu XJ; Corde S; Tehei M; Aghmesheh M; Vine KL; Becker TM; Ranson M
    Sci Rep; 2020 Jan; 10(1):539. PubMed ID: 31953491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer.
    Normanno N; Rossi A; Morabito A; Signoriello S; Bevilacqua S; Di Maio M; Costanzo R; De Luca A; Montanino A; Gridelli C; Rocco G; Perrone F; Gallo C
    Lung Cancer; 2014 Aug; 85(2):314-9. PubMed ID: 24882383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.